Cargando…
Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
AIM: To investigate the clinical utility of serum annexin A2 (ANXA2) as a diagnostic marker for early hepatocellular carcinoma (HCC). METHODS: This study was performed in HCC Clinic of Ain Shams University Hospitals, Cairo, Egypt and included: Group 1: Fifty patients with early stage HCC (Barcelona...
Autores principales: | Shaker, Mohamed K, Abdel Fattah, Hanzada I, Sabbour, Ghada S, Montasser, Iman F, Abdelhakam, Sara M, El Hadidy, Eman, Yousry, Rehab, El Dorry, Ahmed K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368624/ https://www.ncbi.nlm.nih.gov/pubmed/28396717 http://dx.doi.org/10.4254/wjh.v9.i9.469 |
Ejemplares similares
-
Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study
por: Montasser, Mohamed F, et al.
Publicado: (2017) -
Evaluation of Amino Acids Profile as Non-Invasive Biomarkers of Hepatocellular Carcinoma in Egyptians
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2022) -
Hidden Y Chromosome Mosaicism in 48 Egyptian Patients with Turner's Syndrome
por: El-Eshmawy, Mervat M., et al.
Publicado: (2013) -
Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt
por: Shaker, Mohammad Kamal, et al.
Publicado: (2018) -
Serological Biomarkers of Hepatocellular Carcinoma in Egyptian Patients
por: El-Tayeh, Sarmad F., et al.
Publicado: (2012)